Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes

Al-Hatamleh, M. A. I., Hatmal, M. M., Alshaer, W., Rahman, E. N. S. E. A., Mohd-Zahid, M. H., Alhaj-Qasem, D. M., Yean, C. Y., Alias, I. Z., Jaafar, J., Ferji, K., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173930 · Cited by 28

A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19

Barh, D., Tiwari, S., Andrade, B. S., Weener, M. E., Goés‐Neto, A., Azevedo, V., Ghosh, P., Blum, K., & Ganguly, N. K. (2021) · Molecular Omics · doi:10.1039/d0mo00189a · Cited by 28

Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells

Wang, X., Zhao, Y., Yan, F., Wang, T., Sun, W., Feng, N., Wang, W., Wang, H., He, H., Yang, S., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00600-21 · Cited by 28

The Role of High-Density Lipoprotein in COVID-19

Wang, G., Deng, J., Li, J., Wu, C., Dong, H., Wu, S., & Zhong, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720283 · Cited by 28

Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function

Ahmadi, E., Bagherpour, Z., Zarei, E., & Omidkhoda, A. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153782 · Cited by 29

Exploring the Utility of NK Cells in COVID-19

Deng, X., Terunuma, H., & Nieda, M. (2022) · Biomedicines · doi:10.3390/biomedicines10051002 · Cited by 27

Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress

Karu, N., Kindt, A. S. D., van Gammeren, A. J., Ermens, A. A. M., Harms, A. C., Portengen, L., Vermeulen, R. C. H., Dik, W. A., Langerak, A. W., van der Velden, V. H. J., et al. (2022) · Metabolites · doi:10.3390/metabo12070618 · Cited by 29

Microvascular significance of TGF-β axis activation in COVID-19

Arguinchona, L., Zagona‐Prizio, C., Joyce, M. E., Chan, E. D., & Maloney, J. P. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1054690 · Cited by 30

COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen

Schön, M. P., Berking, C., Biedermann, T., Buhl, T., Erpenbeck, L., Eyerich, K., Eyerich, S., Ghoreschi, K., Goebeler, M., Ludwig, R. J., et al. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14169_g · Cited by 28

Targeting arachidonic acid–related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles

Shoieb, S. M., El‐Ghiaty, M. A., & El‐Kadi, A. O. S. (2020) · Emergent Materials · doi:10.1007/s42247-020-00136-8 · Cited by 27

Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution

Ong, E. Z., Kalimuddin, S., Chia, W. C., Ooi, S. H., Koh, C. W., Tan, H. C., Zhang, S. L.-X., Low, J. G. H., Ooi, E. E., & Chan, K. R. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103262 · Cited by 25

Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients

Hasan, M. Z., Islam, S., Matsumoto, K., & Kawai, T. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104792 · Cited by 28

Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium

Gupta, R. K., Nwachuku, E. L., Zusman, B. E., Jha, R. M., & Puccio, A. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257784 · Cited by 27

The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent

Cuevas, V. D., Simón‐Fuentes, M., Orta‐Zavalza, E., Samaniego, R., Sánchez‐Mateos, P., Escribese, M. M., Cimas, F. J., Bustos, M., Pérez‐Diego, M., Ocaña, A., et al. (2021) · Journal of Innate Immunity · doi:10.1159/000519305 · Cited by 27

The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy

Hasankhani, A., Bahrami, A., Tavakoli‐Far, B., Iranshahi, S., Ghaemi, F., Akbarizadeh, M. R., Amin, A. H., Kiasari, B. A., & Shabestari, A. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127358 · Cited by 28

A modular framework for the development of targeted Covid-19 blood transcript profiling panels

Rinchai, D., Kabeer, B. S. A., Toufiq, M., Tatari-Calderone, Z., Deola, S., Brummaier, T., Garand, M., Branco, R. G., Baldwin, N. E., Alfaki, M., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02456-z · Cited by 26

Immune Correlates of COVID-19 Control

Poonia, B., & Kottilil, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569611 · Cited by 26

Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era

Greco, S., Madè, A., Gaetano, C., Devaux, Y., Emanueli, C., & Martelli, F. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02582-8 · Cited by 26

Neutrophil subsets and their differential roles in viral respiratory diseases

Zhang, Y., Wang, Q., Mackay, C. R., Ng, L. G., & Kwok, I. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr1221-345r · Cited by 26

Association of Gut Microbiota with Inflammatory Bowel Disease and COVID-19 Severity: A Possible Outcome of the Altered Immune Response

Kaushal, A., & Noor, R. (2022) · Current Microbiology · doi:10.1007/s00284-022-02877-7 · Cited by 27

During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant

Cavaillon, J. (2023) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-023-08965-1 · Cited by 26

Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?

Guillon, A., Hiemstra, P. S., & Si‐Tahar, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06170-8 · Cited by 25

The risk of COVID-19 for pregnant women: Evidences of molecular alterations associated with preeclampsia in SARS-CoV-2 infection

Beys‐da‐Silva, W. O., da Rosa, R. L., Santi, L., Cagnini, E. F. T., Terraciano, P. B., Guimarães, J. A., Passos, E. P., & Berger, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165999 · Cited by 25

COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes

Fraga‐Silva, T. F. D. C., Maruyama, S. R., Sorgi, C. A., Russo, E. M. D. S., Fernandes, A. P., Cardoso, C. R. D. B., Faccioli, L. H., Dias‐Baruffi, M., & Bonato, V. L. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.599736 · Cited by 26

Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review

Smail, S. W., Saeed, M., Alkasalias, T., Khudhur, Z. O., Younus, D. A., Rajab, M. F., Abdulahad, W. H., Hussain, H. I., Niaz, K., & Safdar, M. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112087 · Cited by 26

The Mechanisms and Animal Models of SARS-CoV-2 Infection

Jia, W., Wang, J., Sun, B., Zhou, J., Shi, Y., & Zhou, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.578825 · Cited by 27

Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach

Rodríguez‐Tomàs, E., Iftimie, S. M., Castañé, H., Baiges‐Gayà, G., Hernández‐Aguilera, A., González-Viñas, M., Castro, A., Camps, J., & Joven, J. (2021) · Antioxidants · doi:10.3390/antiox10060991 · Cited by 25

Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis

MotieGhader, H., Safavi, E., Rezapour, A., Amoodizaj, F. F., & Iranifam, R. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-01410-3 · Cited by 24

Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19

Julian, D. R., Kazakoff, M. A., Patel, A., Jaynes, J. M., Willis, M. S., & Yates, C. C. (2021) · Current Pathobiology Reports · doi:10.1007/s40139-021-00226-0 · Cited by 26

Nano-bubble hydrogen water: An effective therapeutic agent against inflammation related disease caused by viral infection in zebrafish model

Li, C., Cao, Y., Kohei, F., Hao, H., Peng, G., Cheng, C., & Ye, J. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.01.023 · Cited by 25

Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality

Budhraja, A., Basu, A., Gheware, A., Abhilash, D., Rajagopala, S. V., Pakala, S., Sumit, M., Ray, A., Subramanian, A., Mathur, P., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049572 · Cited by 25

A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

Landoni, G., Piemonti, L., Monforte, A. D., Grossi, P., Zangrillo, A., Bucci, E. M., Allegretti, M., Goisis, G., Gavioli, E. M., Patel, N., et al. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00644-6 · Cited by 24

COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy

Khaledi, M., Sameni, F., Yahyazade, S., Radandish, M., Owlia, P., Bagheri, N., Afkhami, H., Mahjoor, M., Esmaelpour, Z., Kohansal, M., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.961027 · Cited by 25

Integrative computational epigenomics to build data-driven gene regulation hypotheses

Chen, T., & Tyagi, S. (2020) · GigaScience · doi:10.1093/gigascience/giaa064 · Cited by 21

Chemokine Regulation During Epidemic Coronavirus Infection

Majumdar, S., & Murphy, P. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.600369 · Cited by 22

Suppression of MDA5-mediated antiviral immune responses by NSP8 of SARS-CoV-2Preprint

Yang, Z., Zhang, X., Wang, F., Wang, P., Kuang, E., & Li, X. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.12.247767 · Cited by 25

Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19

Kahn, R., Schmidt, T., Golestani, K., Mossberg, A., Gullstrand, B., Bengtsson, A. A., & Kahn, F. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5covbcr0720-310rr · Cited by 24

Making a case for using γδ T cells against SARS-CoV-2

Yazdanifar, M., Mashkour, N., & Bertaina, A. (2020) · Critical reviews in microbiology · doi:10.1080/1040841x.2020.1822279 · Cited by 20

Transcriptomic Signatures and Immunomodulatory Treatments for COVID-19 Patients

Li, G., Ruan, S., Zhao, X., Liu, Q., Dou, Y., & Mao, F. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.056 · Cited by 26

COVID-19: the new challenge for rheumatologists. One year later

Puxeddu, I., Ferro, F., Bartoloni, E., Elefante, E., Baldini, C., Scirè, C. A., Talarico, R., Migliorini, P., Mosca, M., & Bombardieri, S. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/si106e · Cited by 26

Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2

Ghaebi, M., Tahmasebi, S., Jozghorbani, M., Sadeghi, A., Thangavelu, L. P., Zekiy, A. O., & Esmaeilzadeh, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119503 · Cited by 22

Flavanol Consumption in Healthy Men Preserves Integrity of Immunological‐Endothelial Barrier Cell Functions: Nutri(epi)genomic Analysis

Milenković, D., Rodriguez‐Mateos, A., Lucosz, M., Istas, G., Declerck, K., Sansone, R., Deenen, R., Köhrer, K., Corral‐Jara, K. F., Altschmied, J., et al. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100991 · Cited by 23

Naïve Human Macrophages Are Refractory to SARS-CoV-2 Infection and Exhibit a Modest Inflammatory Response Early in Infection

Zhang, Z., Penn, R., Barclay, W., & Giotis, E. S. (2022) · Viruses · doi:10.3390/v14020441 · Cited by 25

Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics

Khalid, Z., Ma, H., Raza, M. S., Abbas, M., Naz, Z., Kombe, A. J. K., Zeng, W., He, H., & Jin, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.901848 · Cited by 23

Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis

Yang, Y., Hua, Y., Chen, W., Zheng, H., Wu, H., Qin, S., & Huang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1037856 · Cited by 24

Association of Early Nasopharyngeal Immune Markers With COVID-19 Clinical Outcome: Predictive Value of CCL2/MCP-1

Sierra, B., Pérez, A. B., Aguirre, E., Bracho, C., Valdés, O., Jiménez, N., Rodríguez, W. B., González, G., Ortega, L. M., Montalvo, M. C., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa407 · Cited by 23

The Effectiveness of Photobiomudulation therapy (PBMT) in COVID-19 Infection

Sherafat, S. J., Razaghi, Z., Rostami‐Nejad, M., Rezaei–Tavirani, M., & Razzaghi, M. (2020) · Journal of lasers in medical sciences · doi:10.34172/jlms.2020.s4 · Cited by 23

Therapeutic approaches for SARS-CoV-2 infection

Gupta, A., Pradhan, A., Maurya, V. K., Kumar, S., Theengh, A., Puri, B., & Saxena, S. K. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.026 · Cited by 23

SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells

Singh, Y., Trautwein, C., Fendel, R., Krickeberg, N., Berezhnoy, G., Bissinger, R., Ossowski, S., Salker, M. S., Casadei, N., Rieß, O., et al. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07147 · Cited by 24

Long noncoding RNAs in respiratory viruses: A review

Kesheh, M. M., Mahmoudvand, S., & Shokri, S. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2275 · Cited by 23

Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients

Guo, Y., Li, T., Xia, X., Su, B., Li, H., Feng, Y., Han, J., Wang, X., Jia, L., Bao, Z., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.723585 · Cited by 21

Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation

Alfaro, E., Díaz‐García, E., García-Tovar, S., Zamarrón, E., Mangas-Moro, A., Galera, R., López‐Collazo, E., Rio, F. G., & Cubillos‐Zapata, C. (2022) · Biomolecules · doi:10.3390/biom12030442 · Cited by 23

The Importance of Nutraceuticals in COVID-19: What’s the Role of Resveratrol?

Domi, E., Hoxha, M., Kolovani, E., Tricarico, D., & Zappacosta, B. (2022) · Molecules · doi:10.3390/molecules27082376 · Cited by 22

Therapy Targets SARS-CoV-2 Infection-Induced Cell Death

Zhu, Z., Shi, J., Li, L., Wang, J., Zhao, Y., & Ma, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.870216 · Cited by 23

Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients

Gozzi-Silva, S. C., Oliveira, L. D. M., Alberca, R. W., Pereira, N. Z., Yoshikawa, F. S. Y., Pietrobon, A. J., Yendo, T. M., Andrade, M. M. D. S., Ramos, Y. Á. L., de Brito, C. A., et al. (2022) · Cells · doi:10.3390/cells11213359 · Cited by 23

Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome—A narrative review

Karthik, S., Saraswathi, I., Alarifi, A., Al-Atram, A. A., Mickeymaray, S., Paramasivam, A., Shaikh, S., Jeraud, M., & Alothaim, A. S. (2022) · PeerJ · doi:10.7717/peerj.14227 · Cited by 23

COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders

Quincozes‐Santos, A., da Rosa, R. L., Cagnini, E. F. T., Bobermin, L. D., Berger, M., Guimarães, J. A., Santi, L., & Beys‐da‐Silva, W. O. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100196 · Cited by 23

Reduced Inflammatory Responses to SARS-CoV-2 Infection in Children Presenting to Hospital with COVID-19 in China

Qian, G., Zhang, Y., Xu, Y., Hu, W., Hall, I. P., Yue, J., Lu, H., Ruan, L., Ye, M., & Mei, J. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100831 · Cited by 23

SARS-Cov2 enables anaerobic bacteria (Prevotella, et al) to colonize the lungs disrupting homeostasis, causing long-drawn chronic symptoms, and acute severe symptoms (ARDS, septic shock, clots, arterial stroke) which finds resonance, with key differences, in the ‘forgotten disease’ Lemierre Syndrome, enabled by Epstein Barr VirusPreprint

Chakraborty, S. (2020) · doi:10.31219/osf.io/usztn · Cited by 23

COVID-19: respuesta inmune y perspectivas terapéuticas

Lozada-Requena, I., & Ponce, C. N. (2020) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2020.372.5490 · Cited by 32

Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database

Li, Z., & Yang, L. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.558557 · Cited by 22

A Multidisciplinary Approach to Coronavirus Disease (COVID-19)

Ertürk, A. G., Şahin, A., Ay, E. B., Pelit, E., Bağdatlı, E., Kulu, I., Gül, M., Mesci, S., Eryılmaz, S., Ilter, S. O., et al. (2021) · Molecules · doi:10.3390/molecules26123526 · Cited by 24

Effects of Vitamin D and K on Interleukin-6 in COVID-19

Visser, M. P. J., Dofferhoff, A. S. M., van den Ouweland, J. M. W., van Daal, H., Kramers, C., Schurgers, L. J., Janssen, R., & Walk, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.761191 · Cited by 22

A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases

Wang, J. Y., Roehrl, M. H. A., Roehrl, V. B., & Roehrl, M. H. A. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100147 · Cited by 23

Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by connectivity map-based analysis and in vitro studies

Haider, M., Anand, V., Enayathullah, M. G., Parekh, Y., Ram, S., Kumari, S., Anmol, Panda, G., Shukla, M., Dholakia, D., et al. (2021) · bioRxiv · doi:10.1186/s12906-022-03584-3 · Cited by 9

Emerging Effects of IL-33 on COVID-19

Gao, Y., Cai, L., Li, L., Zhang, Y., Li, J., Luo, C., Wang, Y., & Tao, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113656 · Cited by 23

Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity

Shuaib, M., Adroub, S. A., Mourier, T., Mfarrej, S., Zhang, H., Esau, L. E., Alsomali, A., Alofi, F. S., Ahmad, A. N., Shamsan, A., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01208-0 · Cited by 22

Angiotensin‐converting enzyme 2: A protective factor in regulating disease virulence of SARS‐COV‐2

Mariappan, V., Rao, S. R., & Pillai, A. B. (2020) · IUBMB Life · doi:10.1002/iub.2391 · Cited by 23

Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19

Jarai, B. M., Stillman, Z. S., Bomb, K., Kloxin, A. M., & Fromen, C. A. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01287 · Cited by 22

Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis

Tiwari, R., Mishra, A., Gupta, A., & Nayak, D. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1874532 · Cited by 22

Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells

Friedman, N., Jacob‐Hirsch, J., Drori, Y., Eyal, E., Kol, N., Nayshool, O., Mendelson, E., Rechavi, G., & Mandelboim, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247128 · Cited by 25

A blood RNA transcriptome signature for COVID-19

Kwan, P. K. W., Cross, G. B., Naftalin, C. M., Ahidjo, B. A., Mok, C. K., Fanusi, F., Sari, I. P., Chia, S. C., Kumar, S. K., Alagha, R., et al. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01006-w · Cited by 21

Does Angiotensin II Peak in Response to SARS-CoV-2?

Xavier, L. L., Neves, P. F. R., Paz, L. V., Neves, L. T., Bagatini, P. B., Timmers, L. F. S. M., Rasia‐Filho, A. A., Mestriner, R. G., & Wieck, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577875 · Cited by 21

Revisión narrativa sobre la respuesta inmunitaria frente a coronavirus: descripción general, aplicabilidad para SARS-COV-2 e implicaciones terapéuticas

García‐Salido, A. (2020) · Anales de Pediatría · doi:10.1016/j.anpedi.2020.04.016 · Cited by 21

Potential therapeutic and pharmacological strategies for SARS-CoV2

Ghareeb, D. A., Saleh, S. R., Nofal, M. S., Kaddah, M. M. Y., Hassan, S. F., Seif, I. K., El‐Zahaby, S. A., Khedr, S. M., Kenawy, M. Y., Masoud, A. A., et al. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00520-4 · Cited by 21

The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review

Rizkita, L. D., & Astuti, I. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.03.003 · Cited by 21

He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study

Hu, H., Wang, K., Wang, L., Du, Y., Chen, J., Li, Y., Fan, C., Li, N., Sun, Y., Tu, S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.700498 · Cited by 21

The multi-faceted roles of TGF-β in regulation of immunity to infection

Maizels, R. M. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.05.001 · Cited by 19

Viral Load and Patterns of SARS-CoV-2 Dissemination to the Lungs, Mediastinal Lymph Nodes, and Spleen of Patients with COVID-19 Associated Lymphopenia

Абдуллаев, А. О., Odilov, A., Ershler, M. A., Volkov, A. V., Lipina, T., Gasanova, T., Lebedin, Y. S., Бабиченко, И. И., & Sudarikov, A. B. (2021) · Viruses · doi:10.3390/v13071410 · Cited by 21

Application of omics technology to combat the COVID‐19 pandemic

Yang, J., Yan, Y., & Zhong, W. (2021) · MedComm · doi:10.1002/mco2.90 · Cited by 20

Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19

Kamp, J. C., Neubert, L., Ackermann, M., Stark, H., Werlein, C., Fuge, J., Haverich, A., Tzankov, A., Steinestel, K., Friemann, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031583 · Cited by 21

SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosis

Zheng, Q., Lin, R., Chen, Y., Lv, Q., Zhang, J., Zhai, J., Xu, W., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1058884 · Cited by 20

Natural killer cells for antiviral therapy

Smith, D. M., Schafer, J. R., Tullius, B. P., Witkam, L., & Paust, S. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abl5278 · Cited by 22

Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa?

Geisslinger, F., Vollmar, A. M., & Bartel, K. (2020) · Pharmaceuticals · doi:10.3390/ph13070143 · Cited by 21

Brain and COVID-19 Crosstalk: Pathophysiological and Psychological Manifestations

Verma, K., Amitabh, Prasad, D. N., Kumar, B., & Kohli, E. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00446 · Cited by 23

A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework

Pérez-Moraga, R., Forés-Martos, J., Suay‐García, B., Duval, J. L., Falcó, A., & Climent, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040488 · Cited by 21

Positive Information of COVID-19 and Anxiety: A Moderated Mediation Model of Risk Perception and Intolerance of Uncertainty

Zhao, J., Ye, B., & Ma, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.715929 · Cited by 21

Peroxisomal very long-chain fatty acid transport is targeted by herpesviruses and the antiviral host response

Weinhofer, I., Buda, A., Kunze, M., Palfi, Z., Traunfellner, M., Hesse, S., Villoria-Gonzalez, A., Hofmann, J., Hametner, S., Regelsberger, G., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03867-y · Cited by 20

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure

Uckun, F. M., Carlson, J., Orhan, C., Powell, J., Pizzimenti, N. M., van Wyk, H., Özercan, İ. H., Volk, M., & Şahin, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.594321 · Cited by 20

Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2

Narayanaswamy, V., Pentecost, B. T., Alfandari, D., Chin, E., Minor, K. C., Kastrinakis, A. N., Lieberman, T., Arcaro, K. F., & Leftwich, H. K. (2021) · Breastfeeding Medicine · doi:10.1089/bfm.2021.0082 · Cited by 19

Analysis of laboratory parameters in patients with COVID-19: Experiences from a pandemic hospital

Özdemir, S., Eroğlu, S. E., Algın, A., Akça, H. Ş., Özkan, A., Pala, E., Aydın, M., & Aksel, G. (2021) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.20678 · Cited by 20

Vitamin D can reduce severity in COVID-19 through regulation of PD-L1

Aygün, H. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02210-w · Cited by 20

Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients

Peter, L., Wendering, D. J., Schlickeiser, S., Hoffmann, H., Noster, R., Wagner, D. L., Zarrinrad, G., Münch, S., Picht, S., Schulenberg, S., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.02.012 · Cited by 19

Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient

Manunta, M., Lamorte, G., Ferrari, F., Trombetta, E., Tirone, M., Bianco, C., Cattaneo, A., Santoro, L., Baselli, G., Brasca, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83950-2 · Cited by 20

Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) for Immunomodulation in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)

Velotti, F., Costantini, L., & Merendino, N. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010304 · Cited by 21

Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots

Anirvan, P., Narain, S., Hajizadeh, N., Aloor, F. Z., Singh, S. P., & Satapathy, S. K. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002034 · Cited by 22

Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19

Moustafa, A., Khalel, R. S., & Aziz, R. K. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0068 · Cited by 23

Evidence-based of conjunctival COVID-19 positivity: An Italian experience: Gemelli Against COVID Group

Savastano, M. C., Gambini, G., Savastano, A., Falsini, B., Vico, U. D., Sanguinetti, M., Cattani, P., Marchetti, S., Larici, A. R., Franceschi, F., et al. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120976548 · Cited by 19

Differential alteration trend of white blood cells (WBCs) and monocytes count in severe and non-severe COVID-19 patients within a 7-day follow-up

Pirsalehi, A., Salari, S., Baghestani, A. R., Sanadgol, G., Shirini, D., Baerz, M. M., Abdi, S., Akbari, M. E., & Bashash, D. (2021) · Iranian Journal of Microbiology · doi:10.18502/ijm.v13i1.5486 · Cited by 19

The age again in the eye of the COVID-19 storm: evidence-based decision making

Martín, M. C., Jurado, A., Abad‐Molina, C., Orduña, A., Yarce, O., Navas, A. M., Cunill, V., Escobar, D., Boix, F., Burillo‐Sanz, S., et al. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00237-w · Cited by 19

Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection

Cavalli, E., Petralia, M. C., Basile, M. S., Bramanti, A., Bramanti, P., Nicoletti, F., Spandidos, D. A., Shoenfeld, Y., & Fagone, P. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4702 · Cited by 37

Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cellsPreprint

de Melo, C. V. B., Bhuiyan, M. A., Gatua, W., Kanyerezi, S., Uzairue, L. I., Abechi, P., Kumar, K., Rahmat, J., Giwa, A. O., Mwandira, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.289850 · Cited by 2

Immune transcriptomic analysis on COVID-19 patients with varying clinical presentations identifies severity markers

Abdallah, A. M., Ansari, H., Shuaib, M., Doudin, A., Yassine, H. M., Shah, S. S. U. D., Mir, F., Emara, M., Elzouki, A.-N., & Cyprian, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-04837-0 · Cited by 1

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

Zhou, Z. L., Ren, L., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.017 · Cited by 980

Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse

Gardinassi, L. G., Souza, C. O. S., Sales‐Campos, H., & Fonseca, S. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01636 · Cited by 112